SCHEMBL683368

SCHEMBL683368

CCCCc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL683348 0.95 PPARG (0.59)
SCHEMBL684043 0.92 AGTR2 (0.59)
SCHEMBL9882910 0.92 AGTR2 (0.55)
SCHEMBL7019109 0.88 AGTR2 (0.64)
SCHEMBL18087887 0.86 AGTR2 (0.59)
SCHEMBL8543694 0.86 AGTR2 (0.80)
SCHEMBL18088504 0.85 AGTR2 (0.56)
SCHEMBL7017925 0.85 AGTR2 (0.61)
SCHEMBL7014433 0.85 AGTR2 (0.63)
SCHEMBL7018109 0.85 AGTR2 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269717-A1 NEUROGENESIS BY MODULATING ANGIOTENSIN BRAINCELLS INC. (US) 2011-11-03 US disclosed
US-20110046090-A1 MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS BRAINCELLS INC. (US) 2011-02-24 US disclosed
US-20110046090-A1 MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS BRAINCELLS INC. (US) 2011-02-24 US disclosed